PMC:7195088 / 43552-43607 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1203","span":{"begin":45,"end":48},"obj":"Gene"}],"attributes":[{"id":"A1203","pred":"tao:has_database_id","subj":"1203","obj":"Gene:26503"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Tocilizumab • Increased serum ALT (≤36%) and AST (≤22%)"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T70","span":{"begin":24,"end":29},"obj":"Body_part"}],"attributes":[{"id":"A70","pred":"fma_id","subj":"T70","obj":"http://purl.org/sig/ont/fma/fma63083"}],"text":"Tocilizumab • Increased serum ALT (≤36%) and AST (≤22%)"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T42","span":{"begin":24,"end":29},"obj":"Body_part"}],"attributes":[{"id":"A42","pred":"uberon_id","subj":"T42","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"}],"text":"Tocilizumab • Increased serum ALT (≤36%) and AST (≤22%)"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T251","span":{"begin":36,"end":38},"obj":"http://purl.obolibrary.org/obo/CLO_0001313"},{"id":"T252","span":{"begin":51,"end":53},"obj":"http://purl.obolibrary.org/obo/CLO_0050507"}],"text":"Tocilizumab • Increased serum ALT (≤36%) and AST (≤22%)"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T535","span":{"begin":45,"end":48},"obj":"Chemical"}],"attributes":[{"id":"A535","pred":"chebi_id","subj":"T535","obj":"http://purl.obolibrary.org/obo/CHEBI_76649"}],"text":"Tocilizumab • Increased serum ALT (≤36%) and AST (≤22%)"}

{"project":"LitCovid-sentences","denotations":[{"id":"T334","span":{"begin":0,"end":55},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Tocilizumab • Increased serum ALT (≤36%) and AST (≤22%)"}